ONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET ANONIM SIRKETI Financials Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi
Equities
ONCSM
TREONCO00026
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172 TRY | +0.29% |
|
-1.71% | +14.97% |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 3,568 |
| Enterprise Value (EV) 1 | 3,572 |
| P/E ratio | -44.4 x |
| Yield | - |
| Capitalization / Revenue | 14.8 x |
| EV / Revenue | 14.9 x |
| EV / EBITDA | -134 x |
| EV / FCF | -89,355,764 x |
| FCF Yield | -0% |
| Price to Book | 15.4 x |
| Nbr of stocks (in thousands) | 23,850 |
| Reference price 2 | 149.6 |
| Announcement Date | 4/9/24 |
1TRY in Million2TRY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 128 | 140.5 | 240.5 |
| EBITDA 1 | 77.08 | 41.87 | -26.63 |
| EBIT 1 | 70.37 | 31.96 | -59.64 |
| Operating Margin | 54.98% | 22.74% | -24.8% |
| Earnings before Tax (EBT) 1 | 80.41 | 31.75 | -94.32 |
| Net income 1 | 71.73 | 25.49 | -79.81 |
| Net margin | 56.05% | 18.14% | -33.18% |
| EPS 2 | 303.1 | - | -3.369 |
| Free Cash Flow | - | 2.988 | -39.97 |
| FCF margin | - | 2.13% | -16.62% |
| FCF Conversion (EBITDA) | - | 7.14% | - |
| FCF Conversion (Net income) | - | 11.72% | - |
| Dividend per Share | - | 0.4149 | - |
| Announcement Date | 2/21/23 | 2/21/23 | 4/9/24 |
1TRY in Million2TRY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | 8.55 | 2.4 | 3.82 |
| Net Cash position 1 | - | - | - |
| Leverage (Debt/EBITDA) | 0.1109 x | 0.0572 x | -0.1436 x |
| Free Cash Flow | - | 2.99 | -40 |
| ROE (net income / shareholders' equity) | - | 27.9% | -35% |
| ROA (Net income/ Total Assets) | - | 13.5% | -10.8% |
| Assets 1 | - | 189.5 | 736.4 |
| Book Value Per Share 2 | 197.0 | - | 9.720 |
| Cash Flow per Share 2 | 14.40 | - | 2.450 |
| Capex 1 | 11 | 14 | 27.7 |
| Capex / Sales | 8.57% | 9.93% | 11.53% |
| Announcement Date | 2/21/23 | 2/21/23 | 4/9/24 |
1TRY in Million2TRY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +14.97% | 127M | |
| -41.90% | 2.95B | |
| +19.36% | 1.88B | |
| -1.05% | 1.63B | |
| +33.96% | 1.34B | |
| -16.83% | 959M | |
| -21.96% | 888M | |
| +7.07% | 842M | |
| -26.98% | 623M | |
| +10.85% | 513M |
- Stock Market
- Equities
- ONCSM Stock
- Financials Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi
